Evidence map›Paper›PMID 35451964›Full record

ArticleJMIR cancer2022

Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants.

Dinesh Pal Mudaranthakam, Byron Gajewski, Hope Krebill, James Coulter, Michelle Springer, Elizabeth Calhoun, Dorothy Hughes, Matthew Mayo, Gary Doolittle

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Recruiting Rural Patients for Clinical Research: Lessons From a Colorectal Cancer Screening Trial.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Perceptions of health research participation in rural and urban Pennsylvanians.Journal of clinical and translational science · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Barriers to participation in clinical trials of rural older adult cancer survivors: A qualitative study.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Dinesh Pal MudaranthakamUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0001-9767-1158
Byron GajewskiUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0001-7589-8247
Hope KrebillUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0001-9935-1158
James CoulterUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0002-8500-5112
Michelle SpringerUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0002-1521-1156
Elizabeth CalhounUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0002-2532-8040
Dorothy HughesUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0002-8952-450X
Matthew MayoUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0001-7264-1577
Gary DoolittleUniversity of Kansas Medical Center, Kansas City, KS, United States.ORCID https://orcid.org/0000-0002-9141-449X
University of Kansas Medical Center · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Kalyani Pyaram, Steven Allan Soper · 2019 to 2026
$21.5M
NCI NIH HHS P30 CA168524
6 · The paper itself

Abstract

backgroundThe National Clinical Trials Network program conducts phase 2 or phase 3 treatment trials across all National Cancer Institute's designated cancer centers. Participant accrual across these clinical trials is a critical factor in deciding their success. Cancer centers that cater to rural populations, such as The University of Kansas Cancer Center, have an additional responsibility to ensure rural residents have access and are well represented across these studies.

objectiveThere are scant data available regarding the factors that act as barriers to the accrual of rural residents in these clinical trials. This study aims to use electronic screening logs that were used to gather patient data at several participating sites in The Kansas University of Cancer Center's Catchment area.

methodsScreening log data were used to assess what clinical trial participation barriers are faced by these patients. Additionally, the differences in clinical trial participation barriers were compared between rural and urban participating sites.

resultsAnalysis revealed that the hospital location rural urban category, defined as whether the hospital was in an urban or rural setting, had a medium effect on enrolment of patients in breast cancer and lung cancer trials (Cohen d=0.7). Additionally, the hospital location category had a medium effect on the proportion of recurrent lung cancer cases at the time of screening (d=0.6).

conclusionsIn consideration of the financially hostile nature of cancer treatment as well as geographical and transportation barriers, clinical trials extended to rural communities are uniquely positioned to alleviate the burden of nonmedical costs in trial participation. However, these options can be far less feasible for patients in rural settings. Since the number of patients with cancer who are eligible for a clinical trial is already limited by the stringent eligibility criteria required of such a complex disease, improving accessibility for rural patients should be a greater focus in health policy.

Indexed as

cancercancer patientsclinical trialselectronic screeningelectronic screening logshealth policy epidemiologylung cancerpatientsrural residentsscreening

Identifiers

PMID35451964
PMCPMC9073606
OpenAlexW4224304207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.